Approval From FDA Will Intensify the Global Market of Helicobacter Pylori Non-Invasive Testing

Publisher: The Insight Partners

• According to a new market research study titled ‘Helicobacter Pylori Non-Invasive Testing Market to 2027 – Global Analysis and Forecasts by Test Type, Test Method, End User and Geography. The global Helicobacter pylori non-invasive testing market is expected to reach US$ 768.23 Mn in 2027 from US$ 539.70 Mn in 2018. The market is estimated to grow with a CAGR of 4.1% from 2019-2027. The market is likely to grow due to the increasing prevalence of H. pylori bacterial infection and rising product launches and FDA approval of the helicobacter pylori non-invasive testing by the companies.

Helicobacter pylori is a bacteria that enters into body and live in digestive tract and causes infection. After period of time, it may cause sores, called ulcers, in the lining of your stomach or the upper part of your small intestine. Helicobacter pylori infection are diagnosed by invasive techniques or non-invasive techniques. Invasive techniques may require endoscopy and biopsy (e.g. histological examination, culture and rapid urease test) and for non-invasive, tests used for detection are serology, the urea breath test, urine/blood or detection of Helicobacter pylori antigen in stool specimen.

Global Helicobacter pylori non-invasive testing market was segmented by test type, test method and end user. On the basis of the test type the market is segmented as serology tests, stool antigen tests, and urea breath tests. Based on the test method the market is segmented into laboratory based test and point of care test. And the market is classified into hospitals, clinics, and diagnostic laboratories on the basis of end user. The Helicobacter pylori non-invasive testing market by end user was held largely by the diagnostic laboratories. The increasing number of tests carried out in labs are expected to grow during the forecast years.

The major players operating in the Helicobacter pylori non-invasive testing market include, DiaSorin S.p.A., Meridian Bioscience, Exalenz Bioscience Ltd., Abbott, Thermo Fisher Scientific, Inc., Certest Biotec S.L., Sekisui Diagnostics (Sekisui Chemical Co. Ltd.), CorisBioconcept SPRL, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., and Bio-Rad Laboratories, Inc. among the others.

The report segments the global Helicobacter pylori non-invasive testing market as follows:

Global Helicobacter Pylori Non-Invasive Testing Market – By Test Type

• Serology Tests
• Stool Antigen Tests
• Urea Breath Test

Global Helicobacter Pylori Non-Invasive Testing Market – By Test Method

• Laboratory Based Test
• Point of Care Test

Global Helicobacter Pylori Non-Invasive Testing Market – By End User

• Hospitals
• Clinics
• Diagnostic Laboratories

Global Helicobacter Pylori Non-Invasive Testing Market – By Geography

• North America
  • U.S
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • U.K
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
• South & Central America
  • Brazil
  • Argentina